cAMP levels were quantified in SSc MFs using the cAMP‐GLO assay after treating cells with a cAMP modulating agent in the presence of the non‐specific PDE inhibitor IBMX and PDE4 specific inhibitor Ro 20–1724 for 2 h. This evidence concerns the gene PDE4A and systemic sclerosis.